Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Trends in Stenotrophomonas maltophilia bloodstream infection in relation to usage density of cephalosporins and carbapenems during 7 years.

Paez JG, Levin AS, Basso M, Gomez LB, Gobara S, Spadão F, Oshiro I, Costa SF.

Infect Control Hosp Epidemiol. 2008 Oct;29(10):989-90. doi: 10.1086/591032. No abstract available.

PMID:
18808347
2.

Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.

Lee JC, Vivanco I, Beroukhim R, Huang JH, Feng WL, DeBiasi RM, Yoshimoto K, King JC, Nghiemphu P, Yuza Y, Xu Q, Greulich H, Thomas RK, Paez JG, Peck TC, Linhart DJ, Glatt KA, Getz G, Onofrio R, Ziaugra L, Levine RL, Gabriel S, Kawaguchi T, O'Neill K, Khan H, Liau LM, Nelson SF, Rao PN, Mischel P, Pieper RO, Cloughesy T, Leahy DJ, Sellers WR, Sawyers CL, Meyerson M, Mellinghoff IK.

PLoS Med. 2006 Dec;3(12):e485.

3.

A transforming MET mutation discovered in non-small cell lung cancer using microarray-based resequencing.

Tengs T, Lee JC, Paez JG, Zhao X, LaFramboise T, Giannoukos G, Thomas RK.

Cancer Lett. 2006 Aug 8;239(2):227-33. Epub 2005 Sep 19.

PMID:
16171945
4.

Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.

Bentires-Alj M, Paez JG, David FS, Keilhack H, Halmos B, Naoki K, Maris JM, Richardson A, Bardelli A, Sugarbaker DJ, Richards WG, Du J, Girard L, Minna JD, Loh ML, Fisher DE, Velculescu VE, Vogelstein B, Meyerson M, Sellers WR, Neel BG.

Cancer Res. 2004 Dec 15;64(24):8816-20.

5.

Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML.

Jiang J, Paez JG, Lee JC, Bo R, Stone RM, DeAngelo DJ, Galinsky I, Wolpin BM, Jonasova A, Herman P, Fox EA, Boggon TJ, Eck MJ, Weisberg E, Griffin JD, Gilliland DG, Meyerson M, Sellers WR.

Blood. 2004 Sep 15;104(6):1855-8. Epub 2004 Jun 3.

6.

Genome coverage and sequence fidelity of phi29 polymerase-based multiple strand displacement whole genome amplification.

Paez JG, Lin M, Beroukhim R, Lee JC, Zhao X, Richter DJ, Gabriel S, Herman P, Sasaki H, Altshuler D, Li C, Meyerson M, Sellers WR.

Nucleic Acids Res. 2004 May 18;32(9):e71.

7.

An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays.

Zhao X, Li C, Paez JG, Chin K, Jänne PA, Chen TH, Girard L, Minna J, Christiani D, Leo C, Gray JW, Sellers WR, Meyerson M.

Cancer Res. 2004 May 1;64(9):3060-71.

8.

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE, Meyerson M.

Science. 2004 Jun 4;304(5676):1497-500. Epub 2004 Apr 29.

9.

Partial depletion of intracellular ATP mediates the stress-survival function of the PCPH oncoprotein.

Recio JA, Páez JG, Sanders S, Kawakami T, Notario V.

Cancer Res. 2002 May 1;62(9):2690-4.

10.

Identity between the PCPH proto-oncogene and the CD39L4 (ENTPD5) ectonucleoside triphosphate diphosphohydrolase gene.

Páez JG, Recio JA, Rouzaut A, Notario V.

Int J Oncol. 2001 Dec;19(6):1249-54.

PMID:
11713596
11.

The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.

Shaw RJ, Paez JG, Curto M, Yaktine A, Pruitt WM, Saotome I, O'Bryan JP, Gupta V, Ratner N, Der CJ, Jacks T, McClatchey AI.

Dev Cell. 2001 Jul;1(1):63-72.

12.

Supplemental Content

Support Center